Does LIMAPROST Cause Interstitial lung disease? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Interstitial lung disease have been filed in association with LIMAPROST. This represents 5.2% of all adverse event reports for LIMAPROST.
7
Reports of Interstitial lung disease with LIMAPROST
5.2%
of all LIMAPROST reports
2
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From LIMAPROST?
Of the 7 reports, 2 (28.6%) resulted in death, 6 (85.7%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIMAPROST. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does LIMAPROST Cause?
Pneumonia (16)
Cardiac failure (11)
Pyrexia (10)
Hepatic function abnormal (7)
Renal impairment (7)
Tubulointerstitial nephritis (7)
Dyspnoea (6)
Gait disturbance (6)
Off label use (6)
Anaemia (5)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LIMAPROST Alternatives Have Lower Interstitial lung disease Risk?
LIMAPROST vs LINACLOTIDE
LIMAPROST vs LINAGLIPTIN
LIMAPROST vs LINAGLIPTIN\METFORMIN
LIMAPROST vs LINCOMYCIN
LIMAPROST vs LINEZOLID